Literature DB >> 10884565

The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.

G Griebel1, R J Rodgers, G Perrault, D J Sanger.   

Abstract

Compounds varying in selectivity as 5-HT(1A) receptor antagonists have recently been reported to produce benzodiazepine-like antianxiety effects in mice. To assess the cross-species generality of these findings, the present experiments compared the effects of diazepam (0.625-5 mg/kg) with those of several non-selective (MM-77, 0.03-1 mg/kg and pindobind-5-HT(1A), 0.1-5 mg/kg) and selective (WAY100635, 0.01-10 mg/kg, p-MPPI, 0.01-3 mg/kg and SL88.0338, 0.3-10 mg/kg) 5-HT(1A) receptor antagonists in three well-validated anxiolytic screening tests in rats: punished lever-pressing, punished drinking, and the elevated plus-maze. In the punished lever-pressing conflict test, none of the 5-HT(1A) receptor antagonists modified rates of punished responding, whereas in the punished drinking test, WAY100635 (0.3-1 mg/kg), SL88.0338 (3-10 mg/kg), p-MPPI (1 mg/kg), MM-77 (0.03-0.3 mg/kg), but not pindobind-5-HT(1A), produced clear anticonflict activity. However, the increase in punished responding with the 5-HT(1A) compounds was smaller than that produced by diazepam, indicating weaker anxiolytic-like activity. In the elevated plus-maze test, WAY100635 (0.1-0.3 mg/kg), SL88.0338 (0.3-10 mg/kg), MM-77 (0.01-3 mg/kg), pindobind-5-HT(1A) (0.1-3 mg/kg), but not p-MPPI, showed anxiolytic-like activity on traditional behavioral indices, increasing the percentage of time spent in open arms and the percentage of open arm entries. As was the case in the punished drinking test, the magnitude of the positive effects of the 5-HT(1A) compounds was generally smaller than that of diazepam. Of the ethological measures recorded in the plus-maze, all compounds markedly decreased risk assessment (i.e. attempts) over the entire dose-range, but only diazepam clearly increased directed exploration (i.e. head-dipping). Although the present results demonstrate that 5-HT(1A) receptor antagonists elicit anxiolytic-like effects in rats, this action appears to be test-specific and, unlike previous findings in mice, smaller than that observed with benzodiazepines. The data are discussed in relation to the possible relevance of species differences in 5-HT(1A) receptor function and the nature of the anxiety response studied.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884565     DOI: 10.1016/s0028-3908(00)00074-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

1.  Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea.

Authors:  Daniel I Brierley; James Samuels; Marnie Duncan; Benjamin J Whalley; Claire M Williams
Journal:  Psychopharmacology (Berl)       Date:  2015-10-06       Impact factor: 4.530

2.  The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors.

Authors:  Felipe V Gomes; Leonardo B M Resstel; Francisco S Guimarães
Journal:  Psychopharmacology (Berl)       Date:  2010-10-14       Impact factor: 4.530

3.  Activation of amygdalar metabotropic glutamate receptors modulates anxiety, and risk assessment behaviors in ovariectomized estradiol-treated female rats.

Authors:  María De Jesús-Burgos; Vanessa Torres-Llenza; Nivia L Pérez-Acevedo
Journal:  Pharmacol Biochem Behav       Date:  2012-01-24       Impact factor: 3.533

4.  5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia.

Authors:  Christiaan H Vinkers; Ruud van Oorschot; S Mechiel Korte; Berend Olivier; Lucianne Groenink
Journal:  Psychopharmacology (Berl)       Date:  2010-06-10       Impact factor: 4.530

5.  New imide 5-HT1A receptor ligands - modification of terminal fragment geometry.

Authors:  Andrzej J Bojarski; Maria J Mokrosz; Beata Duszyńska; Aneta Kozioł; Ryszard Bugno
Journal:  Molecules       Date:  2004-02-28       Impact factor: 4.411

6.  Yohimbine is a 5-HT1A agonist in rats in doses exceeding 1 mg/kg.

Authors:  Dmitry V Zaretsky; Maria V Zaretskaia; Joseph A DiMicco; Daniel E Rusyniak
Journal:  Neurosci Lett       Date:  2015-09-12       Impact factor: 3.046

7.  The clinical implications of mouse models of enhanced anxiety.

Authors:  Simone B Sartori; Rainer Landgraf; Nicolas Singewald
Journal:  Future Neurol       Date:  2011-07-01

8.  An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice.

Authors:  N F Correa-Netto; M Y Masukawa; F Nishide; G S Galfano; F Tamura; M K Shimizo; M P Marcato; J G Santos; A Linardi
Journal:  Braz J Med Biol Res       Date:  2017-06-05       Impact factor: 2.590

9.  Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.

Authors:  Karolina Pytka; Anna Partyka; Magdalena Jastrzębska-Więsek; Agata Siwek; Monika Głuch-Lutwin; Barbara Mordyl; Grzegorz Kazek; Anna Rapacz; Adrian Olczyk; Adam Gałuszka; Marian Błachuta; Anna Waszkielewicz; Henryk Marona; Jacek Sapa; Barbara Filipek; Anna Wesołowska
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

10.  Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent.

Authors:  Laura Rombolà; Damiana Scuteri; Chizuko Watanabe; Shinobu Sakurada; Kengo Hamamura; Tsukasa Sakurada; Paolo Tonin; Maria Tiziana Corasaniti; Giacinto Bagetta; Luigi Antonio Morrone
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.